- 全部删除
您的购物车当前为空
CFI-402257 是 Mps1/TTK 激酶的选择性抑制剂(Mps1 Ki = 0.09 nM;EC50 = 6.5 nM),可用于肝细胞癌疾病的研究。


为众多的药物研发团队赋能,
让新药发现更简单!
CFI-402257 是 Mps1/TTK 激酶的选择性抑制剂(Mps1 Ki = 0.09 nM;EC50 = 6.5 nM),可用于肝细胞癌疾病的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 343 | In stock | |
| 5 mg | ¥ 818 | In stock | |
| 10 mg | ¥ 1,260 | In stock | |
| 25 mg | ¥ 2,770 | In stock | |
| 50 mg | ¥ 4,850 | In stock | |
| 100 mg | ¥ 6,730 | In stock |
CFI-402257 相关产品
| 产品描述 | CFI-402257 is a selective inhibitor of Mps1/TTK kinase (Mps1 Ki = 0.09 nM; EC50 = 6.5 nM)and can be used in studies about hepatocellular carcinoma diseases. |
| 靶点活性 | TTK:0.1 nM (Ki), Mps1:0.09 nM (Ki), TTK:1.7 nM, Mps1:6.5 nM (EC50) |
| 分子量 | 498.58 |
| 分子式 | C28H30N6O3 |
| CAS No. | 1610759-22-2 |
| Smiles | N(C[C@H]1C[C@@](C)(O)C1)C=2N3C(=C(C=N3)C4=CC(C)=C(C(NC5CC5)=O)C=C4)N=C(OC=6C=CC=NC6)C2 |
| 密度 | 1.42 g/cm3 (Predicted) |
| 存储 | store at low temperature,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 37.7 mg/mL (75.61 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容